For most farmers and their families, opium cultivation is a means of survival, especially in the context poverty, insecurity, and repression. This film sensitively portrays the lives of two opium farming families in Myanmar and sheds light on their plight.
The voice of communities involved in illicit cultivation had long been excluded from policymaking platforms. However, thanks to growing networks such as the Myanmar Opium Farmers Forum, more and more farmers have gained more space to provide input to drug policy discussions at the UN level.
Countries that embrace legal regulation find themselves in breach of international law. In this video, we explain a strategy to resolve those treaty tensions and to enable progressive and sustainable change at the global level.
On 28 May 2018, the Transnational Institute and the Epicurus Foundation co-hosted the second edition of the “The Transparent Chain,” a conference on transparent cannabis supply chains in Utrecht, Netherlands.
As a growing number of countries move towards legal regulation for non-medical cannabis, governments are pushing the boundaries of the three UN drug control treaties. At the 61st session of the Commission on Narcotic Drugs (CND), TNI co-organised a side event to explore the issue, addressing the various challenges and opportunities involved.
Together with the Cannabis News Network, Martin Jelsma travelled to Colombia to report on the newly emerging medical cannabis industry in the country, specifically looking at the impacts of private investment and licensing on farmers and indigenous communities.
The UN General Assembly Special Session (UNGASS) on drugs – held in New York in April 2016 – was hailed as an opportunity for the international community ‘to conduct a wide-ranging and open debate that considers all options’. Although the UNGASS was characterised by many shortcomings and disappointments, it was nonetheless a critical moment for global drug policy reform.
The voices of affected communities involved in the cultivation of coca leaf, opium poppy and cannabis plants are lacking in the global debate on drug policy reform in general and were at risk of being excluded from the United Nations General Assembly Special Session (UNGASS) 2016 on The World Drug Problem.
To address its serious drug use problems, Myanmar should change its drug policy towards a harm reduction approach. Instead of a repressive approach, voluntary and evidence-based treatment and public health services, including harm reduction, should be made available and become generally accepted by enforcement officials and by the community at large.
A special session of the General Assembly took place in April revealing a growing divergence in the global drug policy landscape. Difficult negotiations resulted in a disappointing outcome document, perpetuating a siloed approach to drugs at the UN level. There is a clear need to realign international drug policies with the overarching 2030 Agenda and the Sustainable Development Goals, embedding the drugs issue comprehensively within the UN’s three pillars: development, human rights, and peace and security. The UNGASS process has helped to set the stage for more substantial changes in the near future, towards the next UN review in 2019.
Opium farmers and representatives of their communities came together to discuss the challenges they face in their lives, and to share experiences and find ways to solve their problems. This is their statement.
With an increasing number of jurisdictions enacting or contemplating reforms creating legal access to cannabis for purposes other than exclusively "medical and scientific," tensions regarding the drug conventions and evolving law and practice in Member States continue to grow.
The 7th GIZ/TNI Asian Informal Drug Policy Dialogue was organised in collaboration with the National Authority for Combating Drugs (NACD) of the Cambodian Government. Key issues on the agenda were recent trends in the drug market in the region and the development of effective policy responses. Specific attention went to the implementation of the UN Guiding Principles on Alternative Development in the Asian context, including in the implementation of alternative development programmes in conflict areas. The involvement of affected communities in policy making and project implementation was another important theme that was discussed. A major aim of the dialogue was to look at the state of the Asian drug policy before UNGASS 2016.
As jurisdictions enact reforms creating legal access to cannabis for purposes other than exclusively “medical and scientific,” tensions surrounding the existing UN drug treaties and evolving law and practice in Member States continue to grow. How might governments and the UN system address these growing tensions in ways that acknowledge the policy shifts underway and help to modernize the drug treaty regime itself, and thereby reinforce the UN pillars of human rights, development, peace and security, and the rule of law?
The Transnational Institute (TNI) attended the 59th session of the UN Commission on Narcotic Drugs in Vienna from the 14-22nd March. The CND negotiated the outcome document to be approved at the 2016 UNGASS on the world drug problem, to be held on April 19-21 in New York.
The Transnational Institute (TNI) attends the 59th session of the UN Commission on Narcotic Drugs in Vienna from the 14-22nd March. This storify features tweets, blogs and news from the event. Our team in Vienna includes Martin Jelsma, Pien Metaal and Tom Blickman.
Producers of prohibited plants face conflict from authorites and the drug market itself. Their communities are stigmatized, criminalized and incarcerated. UN Global drug policy can change this by listening to their demands. Watch our video of the third Global Forum where producers shared experiences and knowledge and ultimately drafted the 'Heemskerk Declaration'
This timeline draws on The Rise and Decline of Cannabis Prohibition that described the history of international control, how cannabis was included in the current UN drug control system and the subsequent defections by countries and states that have brought the international treaties to breaking point. As the UN gathers for a special session on drug policy in 2016, TNI is calling for a revision of the treaties to be based on scientific evidence and embodying principles of harm reduction and human rights.